Phase 2 NSCLC, Stage IIIA Clinical Trials

2 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–2 of 2 trials

Recruiting

Phase 2

Predicting Response to Neoadjuvant ATEZOLIZUMAB Plus Carboplatin/Nab Paclitaxel in Resectable Non-squamous NSCLC

NSCLC Stage IINSCLC, Stage IIIANSCLC Stage IIIB

University Hospital Heidelberg20 enrolled1 locationNCT04865250

Recruiting

Phase 2

Neoadjuvant Nivolumab Combination Treatment in Resectable Non-small Cell Lung Cancer Patients

NSCLC Stage IINSCLC, Stage IIIANSCLC, Stage I

University Hospital, Essen90 enrolled4 locationsNCT04205552